SBC Medical Group Holdings Reports Q3 Revenue Down 18%, Net Income Up 353%
SBC Medical Group Holdings Inc. reported total revenues of $43.0 million for the third quarter of 2025, an 18.0% decrease year-over-year. Income from operations was $16.0 million, reflecting a 15.0% increase compared to the same period in 2024. Net income attributable to the company was $13.0 million, up 353.0% from $3.0 million in the third quarter of 2024, mainly due to lower operating expenses and reduced income tax expense. Earnings per share were $0.12, compared to $0.03 in the prior year period. EBITDA was $17.0 million, a 12.0% increase year-over-year, with an EBITDA margin of 38.0%, up from 28.0% in the third quarter of 2024. The company noted the revenue decrease was associated with the termination of staffing services, deconsolidation of Kijimadairakanko Inc. and Skynet Academy Co., Ltd., and a revision to the fee structure.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. SBC Medical Group Holdings Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001193125-25-281439), on November 14, 2025, and is solely responsible for the information contained therein.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.